Aurobindo Pharma Ltd banner

Aurobindo Pharma Ltd
BSE:524804

Watchlist Manager
Aurobindo Pharma Ltd Logo
Aurobindo Pharma Ltd
BSE:524804
Watchlist
Price: 1 221.55 INR -0.04% Market Closed
Market Cap: ₹715.8B

Wall Street
Price Targets

AUROPHARMA Price Targets Summary
Aurobindo Pharma Ltd

Wall Street analysts forecast AUROPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUROPHARMA is 1 370.24 INR with a low forecast of 1 026.84 INR and a high forecast of 1 716.39 INR.

Lowest
Price Target
1 026.84 INR
16% Downside
Average
Price Target
1 370.24 INR
12% Upside
Highest
Price Target
1 716.39 INR
41% Upside
Aurobindo Pharma Ltd Competitors:
Price Targets
LMB
Limbach Holdings Inc
36% Upside

Revenue
Forecast

16% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
16% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Aurobindo Pharma Ltd's revenue is 16%. The projected CAGR for the next 3 years is 9%.

Operating Income
Forecast

21% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
21% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 13 years the compound annual growth rate for Aurobindo Pharma Ltd's operating income is 21%. The projected CAGR for the next 3 years is 10%.

Net Income
Forecast

N/A
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

The compound annual growth rate of Aurobindo Pharma Ltd's net income for the next 3 years is 13%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AUROPHARMA's stock price target?
Price Target
1 370.24 INR

According to Wall Street analysts, the average 1-year price target for AUROPHARMA is 1 370.24 INR with a low forecast of 1 026.84 INR and a high forecast of 1 716.39 INR.

What is Aurobindo Pharma Ltd's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Aurobindo Pharma Ltd's revenue is 16%. The projected CAGR for the next 3 years is 9%.

What is Aurobindo Pharma Ltd's Operating Income forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Aurobindo Pharma Ltd's operating income is 21%. The projected CAGR for the next 3 years is 10%.

What is Aurobindo Pharma Ltd's Net Income forecast?
Projected CAGR
13%

The compound annual growth rate of Aurobindo Pharma Ltd's net income for the next 3 years is 13%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett